» Articles » PMID: 37602368

Epilepsy and Long-term Risk of Arrhythmias

Overview
Journal Eur Heart J
Date 2023 Aug 21
PMID 37602368
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Previous evidence has mainly supported transient changes in cardiac function during interictal or peri-ictal phases in people with epilepsy, but the long-term risk of cardiac arrhythmias is poorly described. This study aimed to assess the long-term association of epilepsy with cardiac arrhythmias, considering the potential role of genetic predisposition and antiseizure medications (ASMs) in any associations observed.

Methods: This population-based study evaluated UK Biobank data for individuals recruited between 2006 and 2010. Cox proportional hazards models and competing risk models were used to examine the association of epilepsy history with the long-term incidence risk of cardiac arrhythmias and arrhythmias subtypes. Polygenic risk scores (PRS) were calculated to investigate the effect of genetic susceptibility. The role of ASMs was also evaluated by integrating observational and drug target Mendelian randomization (MR) evidence.

Results: The study included 329 432 individuals, including 2699 people with epilepsy. Compared with those without epilepsy, people with epilepsy experienced an increased risk of all cardiac arrhythmias [hazard ratio (HR) 1.36, 95% confidence interval (CI) 1.21-1.53], atrial fibrillation (HR 1.26, 95% CI 1.08-1.46), and other cardiac arrhythmias (HR 1.56, 95% CI 1.34-1.81). The associations were not modified by genetic predisposition as indicated by PRS. Competing and sensitivity analyses corroborated these results. Individuals with epilepsy using ASMs, especially carbamazepine and valproic acid, were at a higher risk for cardiac arrhythmias. This observation was further supported by drug target MR results (PSMR < .05 and PHEIDI > .05).

Conclusion: This study revealed the higher risk of cardiac arrhythmias persists long term in people with epilepsy, especially among those using carbamazepine and valproic acid. These findings highlight the need for regular heart rhythm monitoring and management in people with epilepsy in order to reduce the risk of further cardiovascular complications.

Citing Articles

Management recommendations to reduce cardiac risk in chronic epilepsy.

Pang T, Verrier R, Schachter S Epilepsy Behav Rep. 2025; 29:100738.

PMID: 39975581 PMC: 11835611. DOI: 10.1016/j.ebr.2024.100738.


Cardiovascular Effects of Antiseizure Medications for Epilepsy.

Nei M, Ho J, Ho R CNS Drugs. 2025; 39(4):383-401.

PMID: 39951223 DOI: 10.1007/s40263-025-01163-x.


Cardiac Conduction Delay for Sodium Channel Antagonist Antiseizure Medications: An Analysis of the Canadian Longitudinal Study on Aging.

Shlobin N, Li J, Sander J, Keezer M, Thijs R Neurology. 2025; 104(4):e210302.

PMID: 39899787 PMC: 11793923. DOI: 10.1212/WNL.0000000000210302.


Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome.

Mondejar-Parreno G, Moreno-Manuel A, Ruiz-Robles J, Jalife J Cell Discov. 2025; 11(1):3.

PMID: 39788950 PMC: 11717978. DOI: 10.1038/s41421-024-00738-0.


Enhancing the robustness of Mendelian randomization studies: lessons from a two-sample analysis of viral infections and colorectal cancer.

Yu T, Xia J, Yin H, Yi N, Zhang L, Li M Infect Agent Cancer. 2024; 19(1):60.

PMID: 39639381 PMC: 11619104. DOI: 10.1186/s13027-024-00626-y.


References
1.
Auerbach D, Biton Y, Polonsky B, McNitt S, Gross R, Dirksen R . Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications. Transl Res. 2017; 191:81-92.e7. PMC: 5733703. DOI: 10.1016/j.trsl.2017.10.002. View

2.
Shmuely S, van der Lende M, Lamberts R, Sander J, Thijs R . The heart of epilepsy: Current views and future concepts. Seizure. 2016; 44:176-183. DOI: 10.1016/j.seizure.2016.10.001. View

3.
Park K, Sharma G, Kennedy J, Seyal M . Potentially high-risk cardiac arrhythmias with focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures are associated with the duration of periictal hypoxemia. Epilepsia. 2017; 58(12):2164-2171. DOI: 10.1111/epi.13934. View

4.
Altun Y, Yasar E . Effects of valproate, carbamazepine and levetiracetam on Tp-e interval, Tp-e/QT and Tp-e/QTc ratio. Ideggyogy Sz. 2020; 73(3-4):121-127. DOI: 10.18071/isz.73.0121. View

5.
Surges R, Shmuely S, Dietze C, Ryvlin P, Thijs R . Identifying patients with epilepsy at high risk of cardiac death: signs, risk factors and initial management of high risk of cardiac death. Epileptic Disord. 2021; 23(1):17-39. DOI: 10.1684/epd.2021.1254. View